Your browser doesn't support javascript.
loading
Salvage lenvatinib/everolimus combination therapy after immune checkpoint inhibitor and VEGFR tyrosine kinase inhibitor for metastatic renal cell carcinoma.
Kwok, Christopher; Khorasanchi, Adam; Psutka, Sarah P; Hinkley, Megan; Dason, Shawn; Sundi, Debasish; Yang, Yuanquan; Yang, Yajing; Verschraegen, Claire; Gross, Evan E; Orcutt, Delaney; Yin, Ming.
Afiliación
  • Kwok C; Department of Pharmacy, The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.
  • Khorasanchi A; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.
  • Psutka SP; Department of Urology, University of Washington, Fred Hutchinson Cancer Center, Seattle, WA, United States.
  • Hinkley M; Department of Pharmacy, The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.
  • Dason S; Division of Urologic Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.
  • Sundi D; Division of Urologic Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.
  • Yang Y; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.
  • Yang Y; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.
  • Verschraegen C; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.
  • Gross EE; The University of Washington School of Medicine, Seattle, WA, United States.
  • Orcutt D; The University of Washington School of Medicine, Seattle, WA, United States.
  • Yin M; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.
Front Oncol ; 13: 1231831, 2023.
Article en En | MEDLINE | ID: mdl-37576889
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza